Corebridge Financial Inc. Sells 15,379 Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Corebridge Financial Inc. reduced its stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 3.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 383,650 shares of the real estate investment trust's stock after selling 15,379 shares during the period. Corebridge Financial Inc. owned approximately 0.16% of Sabra Health Care REIT worth $6,645,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the company. VSM Wealth Advisory LLC bought a new stake in shares of Sabra Health Care REIT in the 4th quarter valued at about $26,000. Quarry LP bought a new position in shares of Sabra Health Care REIT during the third quarter valued at approximately $30,000. Assetmark Inc. raised its stake in Sabra Health Care REIT by 33.4% during the fourth quarter. Assetmark Inc. now owns 2,618 shares of the real estate investment trust's stock valued at $45,000 after buying an additional 656 shares during the last quarter. Wilmington Savings Fund Society FSB purchased a new stake in Sabra Health Care REIT during the 3rd quarter valued at about $59,000. Finally, Jones Financial Companies Lllp lifted its position in Sabra Health Care REIT by 208.3% in the 4th quarter. Jones Financial Companies Lllp now owns 6,222 shares of the real estate investment trust's stock valued at $108,000 after acquiring an additional 4,204 shares in the last quarter. 99.40% of the stock is currently owned by institutional investors.

Sabra Health Care REIT Stock Performance

Shares of SBRA traded down $0.07 during midday trading on Monday, reaching $17.47. 1,908,083 shares of the stock were exchanged, compared to its average volume of 2,084,788. Sabra Health Care REIT, Inc. has a twelve month low of $13.31 and a twelve month high of $20.03. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.32 and a quick ratio of 4.16. The company has a market capitalization of $4.16 billion, a price-to-earnings ratio of 32.96, a PEG ratio of 1.97 and a beta of 1.27. The business's 50-day moving average price is $16.83 and its 200 day moving average price is $17.67.

Remove Ads

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last announced its quarterly earnings data on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.36. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. The company had revenue of $182.35 million during the quarter, compared to analysts' expectations of $178.01 million. On average, sell-side analysts expect that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Health Care REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Friday, February 14th were issued a dividend of $0.30 per share. The ex-dividend date was Friday, February 14th. This represents a $1.20 annualized dividend and a yield of 6.87%. Sabra Health Care REIT's payout ratio is presently 226.42%.

Wall Street Analysts Forecast Growth

SBRA has been the topic of several recent research reports. Mizuho reiterated a "neutral" rating and issued a $20.00 price target on shares of Sabra Health Care REIT in a research report on Thursday, December 5th. Truist Financial lifted their price objective on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a "hold" rating in a research note on Tuesday, March 18th. Citizens Jmp upgraded shares of Sabra Health Care REIT from a "hold" rating to a "strong-buy" rating in a report on Tuesday, January 7th. Finally, JMP Securities raised shares of Sabra Health Care REIT from a "market perform" rating to an "outperform" rating and set a $20.00 target price on the stock in a research report on Tuesday, January 7th. Three analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, Sabra Health Care REIT presently has a consensus rating of "Moderate Buy" and a consensus target price of $19.33.

Sabra Health Care REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.